Addresses the legal prescription drug crisis in Canada and provides a roadmap for reducing the harms associated with these drugs. This report presents 58 recommendations to address the harms as developed by the National Advisory Council on…
Examines the co-occurrence of substance use and mental health disorders. It argues that concurrent disorders are a significant health issue, but the system of care for them is fractured.
Describes public health and safety considerations for on-premise cannabis use in locations such as bars, cafés and lounges.
This report summarizes the findings of a six-week online public consultation held in spring 2021 to inform an update of Canada’s Low-Risk Alcohol Drinking Guidelines. It outlines what we heard from more than 4,800 people in Canada, as well as…
Outlines the continuum of care to provide quality treatment for youth who experience harm from psychoactive prescription drugs.
Oral fluid drug screening equipment was approved for legal use by law enforcement in 2018 to detect the presence of certain drugs, including cannabis, in drivers.
Submitted to the Standing Committee on Finance October 2022.
Summarizes the keynotes, panels and breakout discussions held at the 2nd Drug Checking Symposium in February 2025, hosted by the National Drug Checking Working Group in Montreal and virtually.
